Richey, Madeline https://orcid.org/0000-0002-5161-5182
Fullerton, Christina
Zhang, Qianyi https://orcid.org/0000-0002-7850-6701
Williams, Tori
Donnelly, Douglas
Wise, Hannah C. https://orcid.org/0000-0001-6443-0390
Dolor, Aaron
Wadé, Niquelle
Magee, Kelly https://orcid.org/0000-0002-2511-4966
Article History
Received: 4 December 2024
Accepted: 11 February 2025
First Online: 3 March 2025
Declarations
:
: At the time the study was conducted, Madeline Richey, Christina Fullerton, Qianyi Zhang, Tori Williams, Douglas Donnelly, Hannah C. Wise, Aaron Dolor, Niquelle Wadé, and Kelly Magee report employment at Flatiron Health, Inc., which is an independent member of the Roche Group, and stock ownership in Roche.
: This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments. IRB approval of the study protocol, with a waiver of informed consent, was obtained before study conduct and covers the data from all sites represented. Approval was granted by the WCG IRB. (“The Flatiron Health Real-World Evidence Parent Protocol”; IRB registration number IRB00000533; Protocol approval ID tracking number 420180044.)